Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Physical Performance of a Long Axial Field of View PET Scanner Prototype with Sparse Rings Configuration: A Monte Carlo Simulation Study.

Zein SA, Karakatsanis NA, Issa M, Haj-Ali AA, Nehmeh SA.

Med Phys. 2020 Jan 27. doi: 10.1002/mp.14046. [Epub ahead of print]

PMID:
31985827
2.

Assessing the qualitative and quantitative impacts of simple two-class vs multiple tissue-class MR-based attenuation correction for cardiac PET/MR.

Robson PM, Vergani V, Benkert T, Trivieri MG, Karakatsanis NA, Abgral R, Dweck MR, Moreno PR, Kovacic JC, Block KT, Fayad ZA.

J Nucl Cardiol. 2020 Jan 2. doi: 10.1007/s12350-019-02002-5. [Epub ahead of print]

PMID:
31898004
3.

Iterative reconstruction incorporating background correction improves quantification of [18F]-NaF PET/CT images of patients with abdominal aortic aneurysm.

Akerele MI, Karakatsanis NA, Forsythe RO, Dweck MR, Syed M, Aykroyd RG, Sourbron S, Newby DE, Tsoumpas C.

J Nucl Cardiol. 2019 Nov 11. doi: 10.1007/s12350-019-01940-4. [Epub ahead of print]

4.

Hybrid PET- and MR-driven attenuation correction for enhanced 18F-NaF and 18F-FDG quantification in cardiovascular PET/MR imaging.

Karakatsanis NA, Abgral R, Trivieri MG, Dweck MR, Robson PM, Calcagno C, Boeykens G, Senders ML, Mulder WJM, Tsoumpas C, Fayad ZA.

J Nucl Cardiol. 2019 Oct 30. doi: 10.1007/s12350-019-01928-0. [Epub ahead of print]

PMID:
31667675
5.

Imaging-assisted nanoimmunotherapy for atherosclerosis in multiple species.

Binderup T, Duivenvoorden R, Fay F, van Leent MMT, Malkus J, Baxter S, Ishino S, Zhao Y, Sanchez-Gaytan B, Teunissen AJP, Frederico YCA, Tang J, Carlucci G, Lyashchenko S, Calcagno C, Karakatsanis N, Soultanidis G, Senders ML, Robson PM, Mani V, Ramachandran S, Lobatto ME, Hutten BA, Granada JF, Reiner T, Swirski FK, Nahrendorf M, Kjaer A, Fisher EA, Fayad ZA, Pérez-Medina C, Mulder WJM.

Sci Transl Med. 2019 Aug 21;11(506). pii: eaaw7736. doi: 10.1126/scitranslmed.aaw7736.

PMID:
31434756
6.

Imager-4D: New Software for Viewing Dynamic PET Scans and Extracting Radiomic Parameters from PET Data.

Rowe SP, Solnes LB, Yin Y, Kitchen G, Lodge MA, Karakatsanis NA, Rahmim A, Pomper MG, Leal JP.

J Digit Imaging. 2019 Dec;32(6):1071-1080. doi: 10.1007/s10278-019-00255-7.

PMID:
31388864
7.

Gallium-68 DOTATATE PET in the Evaluation of Intracranial Meningiomas.

Ivanidze J, Roytman M, Lin E, Magge RS, Pisapia DJ, Liechty B, Karakatsanis N, Ramakrishna R, Knisely J, Schwartz TH, Osborne JR, Pannullo SC.

J Neuroimaging. 2019 Sep;29(5):650-656. doi: 10.1111/jon.12632. Epub 2019 May 20.

PMID:
31107591
8.

Author Correction: Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates.

Lameijer M, Binderup T, van Leent MMT, Senders ML, Fay F, Malkus J, Sanchez-Gaytan BL, Teunissen AJP, Karakatsanis N, Robson P, Zhou X, Ye Y, Wojtkiewicz G, Tang J, Seijkens TTP, Kroon J, Stroes ESG, Kjaer A, Ochando J, Reiner T, Pérez-Medina C, Calcagno C, Fisher EA, Zhang B, Temel RE, Swirski FK, Nahrendorf M, Fayad ZA, Lutgens E, Mulder WJM, Duivenvoorden R.

Nat Biomed Eng. 2018 Aug;2(8):623. doi: 10.1038/s41551-018-0281-3.

PMID:
31015637
9.

Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates.

Lameijer M, Binderup T, van Leent MMT, Senders ML, Fay F, Malkus J, Sanchez-Gaytan BL, Teunissen AJP, Karakatsanis N, Robson P, Zhou X, Ye Y, Wojtkiewicz G, Tang J, Seijkens TTP, Kroon J, Stroes ESG, Kjaer A, Ochando J, Reiner T, Pérez-Medina C, Calcagno C, Fisher EA, Zhang B, Temel RE, Swirski FK, Nahrendorf M, Fayad ZA, Lutgens E, Mulder WJM, Duivenvoorden R.

Nat Biomed Eng. 2018 May;2(5):279-292. doi: 10.1038/s41551-018-0221-2. Epub 2018 Apr 16. Erratum in: Nat Biomed Eng. 2018 Aug;2(8):623.

10.

A systematic performance evaluation of head motion correction techniques for 3 commercial PET scanners using a reproducible experimental acquisition protocol.

Inomata T, Watanuki S, Odagiri H, Nambu T, Karakatsanis NA, Ito H, Watabe H, Tashiro M, Shidahara M.

Ann Nucl Med. 2019 Jul;33(7):459-470. doi: 10.1007/s12149-019-01353-w. Epub 2019 Mar 29.

PMID:
30924048
11.

Impact of Tissue Classification in MRI-Guided Attenuation Correction on Whole-Body Patlak PET/MRI.

Zhuang M, Karakatsanis NA, Dierckx RAJO, Zaidi H.

Mol Imaging Biol. 2019 Dec;21(6):1147-1156. doi: 10.1007/s11307-019-01338-1.

PMID:
30838550
12.

Hybrid PET/MR Kernelised Expectation Maximisation Reconstruction for Improved Image-Derived Estimation of the Input Function from the Aorta of Rabbits.

Deidda D, Karakatsanis NA, Robson PM, Calcagno C, Senders ML, Mulder WJM, Fayad ZA, Aykroyd RG, Tsoumpas C.

Contrast Media Mol Imaging. 2019 Jan 16;2019:3438093. doi: 10.1155/2019/3438093. eCollection 2019.

13.

Does whole-body Patlak 18F-FDG PET imaging improve lesion detectability in clinical oncology?

Fahrni G, Karakatsanis NA, Di Domenicantonio G, Garibotto V, Zaidi H.

Eur Radiol. 2019 Sep;29(9):4812-4821. doi: 10.1007/s00330-018-5966-1. Epub 2019 Jan 28.

PMID:
30689031
14.

Correction of respiratory and cardiac motion in cardiac PET/MR using MR-based motion modeling.

Robson PM, Trivieri M, Karakatsanis NA, Padilla M, Abgral R, Dweck MR, Kovacic JC, Fayad ZA.

Phys Med Biol. 2018 Nov 14;63(22):225011. doi: 10.1088/1361-6560/aaea97.

15.

Nanobody-Facilitated Multiparametric PET/MRI Phenotyping of Atherosclerosis.

Senders ML, Hernot S, Carlucci G, van de Voort JC, Fay F, Calcagno C, Tang J, Alaarg A, Zhao Y, Ishino S, Palmisano A, Boeykens G, Meerwaldt AE, Sanchez-Gaytan BL, Baxter S, Zendman L, Lobatto ME, Karakatsanis NA, Robson PM, Broisat A, Raes G, Lewis JS, Tsimikas S, Reiner T, Fayad ZA, Devoogdt N, Mulder WJM, Pérez-Medina C.

JACC Cardiovasc Imaging. 2019 Oct;12(10):2015-2026. doi: 10.1016/j.jcmg.2018.07.027. Epub 2018 Oct 17.

16.

Dynamic whole-body PET imaging: principles, potentials and applications.

Rahmim A, Lodge MA, Karakatsanis NA, Panin VY, Zhou Y, McMillan A, Cho S, Zaidi H, Casey ME, Wahl RL.

Eur J Nucl Med Mol Imaging. 2019 Feb;46(2):501-518. doi: 10.1007/s00259-018-4153-6. Epub 2018 Sep 29. Review.

PMID:
30269154
17.

Improved myocardial perfusion PET imaging with MRI assisted reconstruction incorporating multi-resolution joint entropy.

Wang X, Yang B, Adams MP, Gao X, Karakatsanis NA, Tang J.

Phys Med Biol. 2018 Sep 6;63(17):175017. doi: 10.1088/1361-6560/aad8f9.

PMID:
30088809
18.

Quantitative Analysis of Heterogeneous [18F]FDG Static (SUV) vs. Patlak (Ki) Whole-body PET Imaging Using Different Segmentation Methods: a Simulation Study.

Zhuang M, Karakatsanis NA, Dierckx RAJO, Zaidi H.

Mol Imaging Biol. 2019 Apr;21(2):317-327. doi: 10.1007/s11307-018-1241-8.

PMID:
29956119
19.

Assessment of atherosclerotic plaque activity in patients with sleep apnea using hybrid positron emission tomography/magnetic resonance imaging (PET/MRI): a feasibility study.

Kundel V, Trivieri MG, Karakatsanis NA, Robson PM, Mani V, Kizer JR, Kaplan R, Fayad Z, Shah N.

Sleep Breath. 2018 Dec;22(4):1125-1135. doi: 10.1007/s11325-018-1646-2. Epub 2018 Mar 5.

20.

Towards enhanced PET quantification in clinical oncology.

Zaidi H, Karakatsanis N.

Br J Radiol. 2018 Jan;91(1081):20170508. doi: 10.1259/bjr.20170508. Epub 2017 Nov 22. Review.

21.

Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis.

Dweck MR, Abgral R, Trivieri MG, Robson PM, Karakatsanis N, Mani V, Palmisano A, Miller MA, Lala A, Chang HL, Sanz J, Contreras J, Narula J, Fuster V, Padilla M, Fayad ZA, Kovacic JC.

JACC Cardiovasc Imaging. 2018 Jan;11(1):94-107. doi: 10.1016/j.jcmg.2017.02.021. Epub 2017 Jun 14.

22.

Generalized PSF modeling for optimized quantitation in PET imaging.

Ashrafinia S, Mohy-Ud-Din H, Karakatsanis NA, Jha AK, Casey ME, Kadrmas DJ, Rahmim A.

Phys Med Biol. 2017 Jun 21;62(12):5149-5179. doi: 10.1088/1361-6560/aa6911. Epub 2017 Mar 24.

PMID:
28338471
23.

Coronary Artery PET/MR Imaging: Feasibility, Limitations, and Solutions.

Robson PM, Dweck MR, Trivieri MG, Abgral R, Karakatsanis NA, Contreras J, Gidwani U, Narula JP, Fuster V, Kovacic JC, Fayad ZA.

JACC Cardiovasc Imaging. 2017 Oct;10(10 Pt A):1103-1112. doi: 10.1016/j.jcmg.2016.09.029. Epub 2017 Jan 18.

24.

18F-Sodium Fluoride PET/MR for the Assessment of Cardiac Amyloidosis.

Trivieri MG, Dweck MR, Abgral R, Robson PM, Karakatsanis NA, Lala A, Contreras J, Sahni G, Gopalan R, Gorevic P, Fuster V, Narula J, Fayad ZA.

J Am Coll Cardiol. 2016 Dec 20;68(24):2712-2714. doi: 10.1016/j.jacc.2016.09.953. No abstract available.

25.

Quantitative PET image reconstruction employing nested expectation-maximization deconvolution for motion compensation.

Karakatsanis NA, Tsoumpas C, Zaidi H.

Comput Med Imaging Graph. 2017 Sep;60:11-21. doi: 10.1016/j.compmedimag.2016.11.006. Epub 2016 Nov 16.

26.

Whole-body direct 4D parametric PET imaging employing nested generalized Patlak expectation-maximization reconstruction.

Karakatsanis NA, Casey ME, Lodge MA, Rahmim A, Zaidi H.

Phys Med Biol. 2016 Aug 7;61(15):5456-85. doi: 10.1088/0031-9155/61/15/5456. Epub 2016 Jul 6.

27.

Clinical Utility of Combined FDG-PET/MR to Assess Myocardial Disease.

Abgral R, Dweck MR, Trivieri MG, Robson PM, Karakatsanis N, Mani V, Padilla M, Miller M, Lala A, Sanz J, Narula J, Fuster V, Contreras J, Kovacic JC, Fayad ZA.

JACC Cardiovasc Imaging. 2017 May;10(5):594-597. doi: 10.1016/j.jcmg.2016.02.029. Epub 2016 Jun 29. No abstract available.

28.

Dosage optimization in positron emission tomography: state-of-the-art methods and future prospects.

Karakatsanis NA, Fokou E, Tsoumpas C.

Am J Nucl Med Mol Imaging. 2015 Oct 12;5(5):527-47. eCollection 2015. Review.

29.

Generalized whole-body Patlak parametric imaging for enhanced quantification in clinical PET.

Karakatsanis NA, Zhou Y, Lodge MA, Casey ME, Wahl RL, Zaidi H, Rahmim A.

Phys Med Biol. 2015 Nov 21;60(22):8643-73. doi: 10.1088/0031-9155/60/22/8643. Epub 2015 Oct 28.

30.

Estimation of dynamic time activity curves from dynamic cardiac SPECT imaging.

Hossain J, Du Y, Links J, Rahmim A, Karakatsanis N, Akhbardeh A, Lyons J, Frey EC.

Phys Med Biol. 2015 Apr 21;60(8):3193-208. doi: 10.1088/0031-9155/60/8/3193. Epub 2015 Mar 27.

PMID:
25813219
31.

[Comparative study of the operation of two day's Hospitals in Athens].

Mantonakis J, Karakatsanis N, Spilioti E, Karanikoli I, Stentoumis C, Stefanis C.

Psychiatriki. 2014 Apr-Jun;25(2):111-8. Greek, Modern.

PMID:
25035180
32.

Effect of 176Lu intrinsic radioactivity on dual head PET system imaging and data acquisition, simulation, and experimental measurements.

Efthimiou N, Loudos G, Karakatsanis NA, Panayiotakis GS.

Med Phys. 2013 Nov;40(11):112505. doi: 10.1118/1.4824694.

PMID:
24320464
33.

Dynamic whole-body PET parametric imaging: II. Task-oriented statistical estimation.

Karakatsanis NA, Lodge MA, Zhou Y, Wahl RL, Rahmim A.

Phys Med Biol. 2013 Oct 21;58(20):7419-45. doi: 10.1088/0031-9155/58/20/7419. Epub 2013 Sep 30.

34.

Dynamic whole-body PET parametric imaging: I. Concept, acquisition protocol optimization and clinical application.

Karakatsanis NA, Lodge MA, Tahari AK, Zhou Y, Wahl RL, Rahmim A.

Phys Med Biol. 2013 Oct 21;58(20):7391-418. doi: 10.1088/0031-9155/58/20/7391. Epub 2013 Sep 30.

35.

Temporal processing dysfunction in schizophrenia as measured by time interval discrimination and tempo reproduction tasks.

Papageorgiou C, Karanasiou IS, Kapsali F, Stachtea X, Kyprianou M, Tsianaka EI, Karakatsanis NA, Rabavilas AD, Uzunoglu NK, Papadimitriou GN.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jan 10;40:173-9.

PMID:
23367507
36.

3.5D dynamic PET image reconstruction incorporating kinetics-based clusters.

Lu L, Karakatsanis NA, Tang J, Chen W, Rahmim A.

Phys Med Biol. 2012 Aug 7;57(15):5035-55. doi: 10.1088/0031-9155/57/15/5035.

37.

Reversal of increased arterial stiffness in severely depressed women after 6-week antidepressant treatment.

Oulis P, Kouzoupis A, Kyrkou K, Masdrakis VG, Georgiopoulos G, Karapoulios E, Georgiou S, Karakatsanis NA, Lykka M, Papadimitriou GN, Papamichael C, Stamatelopoulos K.

J Affect Disord. 2010 Apr;122(1-2):164-6. doi: 10.1016/j.jad.2009.08.003. Epub 2009 Sep 3.

PMID:
19729203
38.

Quetiapine-induced dose-dependent hypersalivation in mania.

Oulis P, Masdrakis VG, Karakatsanis NA, Kouzoupis AV, Papadimitriou GN.

Clin Neuropharmacol. 2009 Jan-Feb;32(1):56-7. doi: 10.1097/WNF.0b013e3181634e8e. No abstract available.

PMID:
19471187
39.

A radionuclide dosimetry toolkit based on material-specific Monte Carlo dose kernels.

Loudos G, Tsougos I, Boukis S, Karakatsanis N, Georgoulias P, Theodorou K, Nikita K, Kappas C.

Nucl Med Commun. 2009 Jul;30(7):504-12. doi: 10.1097/MNM.0b013e3283299a11.

PMID:
19430322
40.

For publication: Tiagabine in the discontinuation of long-term benzodiazepine use.

Oulis P, Masdrakis VG, Karapoulios E, Karakatsanis NA, Kouzoupis AV, Papadimitriou GN.

Psychiatry Clin Neurosci. 2009 Feb;63(1):122. doi: 10.1111/j.1440-1819.2008.01890.x. No abstract available.

41.

Remission of migraine attacks in a patient with depression who is taking pregabalin.

Masdrakis VG, Oulis P, Karakatsanis NA, Potagas C, Kouzoupis AV, Soldatos CR.

Clin Neuropharmacol. 2008 Jul-Aug;31(4):238-40. doi: 10.1097/WNF.0b013e31814a62e1.

PMID:
18670248
42.

Pregabalin augmentation to sertraline-risperidone combination in the treatment of obsessive-compulsive disorder.

Oulis P, Masdrakis VG, Karapoulios E, Karakatsanis NA, Kouzoupis AV, Konstantakopoulos G, Soldatos CR.

Prim Care Companion J Clin Psychiatry. 2008;10(3):249. No abstract available.

43.

The safety of the electroconvulsive therapy-aripiprazole combination: four case reports.

Masdrakis VG, Oulis P, Zervas IM, Karakatsanis NA, Kouzoupis AV, Karapoulios E, Soldatos CR.

J ECT. 2008 Sep;24(3):236-8. doi: 10.1097/YCT.0b013e3181571c0e.

PMID:
18562946
44.

Pregabalin in the discontinuation of long-term benzodiazepines' use.

Oulis P, Konstantakopoulos G, Kouzoupis AV, Masdrakis VG, Karakatsanis NA, Karapoulios E, Kontoangelos KA, Papadimitriou GN.

Hum Psychopharmacol. 2008 Jun;23(4):337-40. doi: 10.1002/hup.937.

PMID:
18348245
45.

Pregabalin in the discontinuation of long-term benzodiazepine use: a case-series.

Oulis P, Masdrakis VG, Karakatsanis NA, Karapoulios E, Kouzoupis AV, Konstantakopoulos G, Soldatos CR.

Int Clin Psychopharmacol. 2008 Mar;23(2):110-2. doi: 10.1097/YIC.0b013e3282f2b4b2.

PMID:
18301126
46.

Duloxetine-induced cutaneous adverse reaction.

Oulis P, Masdrakis VG, Karakatsanis NA, Karapoulios E, Kouzoupis AV, Soldatos CR.

J Clin Psychopharmacol. 2008 Feb;28(1):104-5. doi: 10.1097/jcp.0b013e318160863e. No abstract available.

PMID:
18204353
47.

Tiagabine augmentation to fluvoxamine-risperidone combination in the treatment of obsessive-compulsive disorder.

Oulis P, Masdrakis VG, Karapoulios E, Karakatsanis NA, Kouzoupis AV, Konstantakopoulos G, Soldatos CR.

World J Biol Psychiatry. 2009;10(4 Pt 3):953-5. doi: 10.1080/15622970701739526.

PMID:
19224410
48.

Oxcarbazepine as monotherapy of acute mania in insufficiently controlled type-1 diabetes mellitus: a case-report.

Oulis P, Karapoulios E, Kouzoupis AV, Masdrakis VG, Kontoangelos KA, Makrilakis K, Karakatsanis NA, Papageorgiou C, Katsilambros N, Soldatos CR.

Ann Gen Psychiatry. 2007 Oct 8;6:25.

49.

Levetiracetam in the treatment of antipsychotics-resistant Tourette syndrome.

Oulis P, Karapoulios E, Masdrakis VG, Kouzoupis AV, Karakatsanis NA, Papageorgiou C, Papadimitriou GN, Soldatos CR.

World J Biol Psychiatry. 2008;9(1):76-7.

PMID:
17853302

Supplemental Content

Loading ...
Support Center